FutureFuel (FF) Q3 2026 earnings review
FutureFuel's fuel sales jump, but high soybean costs erase profits
FutureFuel, a maker of biodiesel and specialty chemicals, ran its fuel plant hard but swung back into the red as raw material costs bit and chemical units went down for maintenance. Revenue climbed 33% from the second quarter to $105 million as biodiesel plant utilization reached 83%. Yet high soybean oil prices and $8.7 million in hedging losses drove a $5 million Adjusted EBITDA loss, while customer maintenance pauses cut chemical volumes. Chief executive Roeland Polet kept his positive full-year Adjusted EBITDA outlook by targeting about $7 million in the fourth quarter.
| Revenue | $104.7M +33% from last quarter (+361% vs idled year-ago) |
|---|---|
| Biofuels gross loss | -$9.8M +$10.1M profit last quarter |
| Adjusted EBITDA | -$4.9M +$11.8M last quarter |
| Full-year Adjusted EBITDA outlook | Unchanged Positive (~$7M targeted for Q4) |
⚖️ Verdict: 🔴 Bearish
The story got worse because running the biodiesel plant near full speed still lost money on raw materials. Even after adding back $4 million of fuel credits and hedge recoveries delayed into next quarter, the biofuel division lost about $6 million by our math, proving that second-quarter profits leaned on one-time hedging gains. On the brighter side, fourth-quarter fuel capacity is over 90% booked, chemical maintenance is finished, and a large European chemical buyer signed on to reshore production in 2027.
The question now is whether fourth-quarter biofuel profits can hold up once the delayed third-quarter credits and hedge recoveries pass through. Either federal blending rules and tighter renewable diesel credits lift fuel prices enough to cover expensive soybean oil, or biodiesel stays a cash drain that eats up specialty chemical gains. Fourth-quarter biofuel gross profit and the 2027 glycerin refining launch will settle it.
🐂 Bull Case
Federal Blending Rules Filled the Biodiesel Plant
FutureFuel makes biodiesel and specialty chemicals at its plant in Batesville, Arkansas. After idling the fuel line during last year's policy delays, the company is now seeing strong orders from federal renewable fuel mandates. Chief executive Roeland Polet said the group has "booked orders for more than 90% of our fourth quarter biodiesel production capacity, well ahead of prior expectations."
Biofuel sales rose 66% from the second quarter to $87.8 million as plant utilization climbed from 56% to 83%. Sales volume jumped by 11.3 million gallons from a year ago, and Polet expects new rules that reduce credit advantages for rival renewable diesel to lift demand further in 2027. High factory utilization also helped the chemicals division absorb its fixed site costs.
What to watch: fourth-quarter biofuel capacity utilization and whether booked orders stay near 90% into early 2027. Keeping the fuel line Above 80% utilization would spread fixed factory overhead across both business segments.
European Reshoring and Customer Funding Expand Chemicals
FutureFuel builds dedicated production units for chemical buyers who help pay for the equipment. In the third quarter, the chemical maker signed a large European customer that is "reshoring production to the United States to better serve its customers and capture the cost advantages of U.S. manufacturing," Polet said, citing cheaper American natural gas.
First batches for the European buyer start in the first quarter of 2027 and reach full rates by mid-year. Meanwhile, a new product line that started late last year lifted performance chemical sales 223% from a year ago to $3.6 million. Customer-funded capital spending will rise from $10.2 million in 2026 to more than $26 million in 2027.
What to watch: first-quarter 2027 batch shipments for the European customer and the pace of customer capital deposits. Delivering those batches on schedule would show the company can turn its engineering pipeline into recurring revenue without draining its own cash.
🐻 Bear Case
High Soybean Oil Costs Wiped Out Biofuel Gains
Polet said the third quarter showed "strong biodiesel demand and improved production economics," and last quarter's $10.1 million biofuel gross profit suggested the segment had turned the corner. In reality, a $9.1 million hedging gain from the first quarter carried that second-quarter profit, and the third quarter exposed the underlying squeeze from raw materials.
Even with biodiesel production at multi-year highs, the biofuel division posted a $9.8 million gross loss. Company-wide cost of goods sold jumped from 80.9% of revenue in the second quarter to 105.2% in the third, because "input costs for soybean oil and other raw materials remain elevated," FutureFuel said.
- Reported biofuel gross loss: $9.8 million on $87.8 million of sales
- Realized hedging losses on unsold inventory: $2.3 million, expected back in Q4
- Unsold renewable fuel credits (RINs, tradeable compliance certificates): $1.5 million held for Q4
- Underlying biofuel gross loss after both timing items: $6.0 million by our math
This matters because running the fuel plant at 83% capacity still lost money before timing shifts. Even if FutureFuel recovers all $3.8 million of delayed credits and hedges in the fourth quarter, high soybean oil prices keep per-gallon profit under pressure.
What to watch: fourth-quarter biofuel gross profit after backing out the $3.8 million of third-quarter RINs and hedge recoveries. Another underlying loss would show that federal fuel mandates fill the factory without fixing the soybean oil margin squeeze.
Maintenance and Customer Delays Cut Chemical Output
FutureFuel relies on a single manufacturing site in Arkansas and a concentrated group of custom chemical buyers, where operational pauses have hit results for three straight quarters. After a winter storm shut the site for 30 days in the first quarter and a fuel outage hit the second, extended maintenance on two chemical units cut third-quarter chemical volumes by 27% from a year ago.
One unit went down for scheduled work, while the company pulled forward maintenance on a second unit "where a customer paused their normal order cadence to rebalance inventory levels," Polet said. Chemical capacity utilization fell by half from the second quarter to 32%, and revenue dropped 35% from last quarter to $16.9 million. Together, the two shutdowns reduced Adjusted EBITDA by about $4.3 million.
What to watch: fourth-quarter custom chemical revenue and plant utilization, with no major maintenance planned through the first quarter of 2027. A rebound above last year's 55% third-quarter utilization would confirm the customer inventory pause has ended.
Risks This Quarter Didn't Answer
Several standing financial and operational questions received no update in the third-quarter earnings release and await the quarterly filing or conference call.
- Clean-fuel tax credit cash: management previously projected $3 million in third-quarter proceeds and $19 million in the fourth quarter, but the release gave no collection figure.
- Energy-market dependence: the release credited energy-market volumes for higher chemical profit, without disclosing how much of the segment relies on oil and gas buyers.
- Customer-funding mix: the full-year capital plan now shows $10.2 million of customer funding on $25.8 million of spending (40% by our math), below the 65% target set in the first quarter.
- Bill-and-hold and related-party sales: unshipped custom chemical inventory and affiliate fuel blending terms require the quarterly filing footnote tables.
👓 Other Themes
Glycerin Upgrading Targets Up to $10M Profit
FutureFuel hired outside advisers to cut plant costs and began a project for "re-refining waste streams into higher-value products," Polet said. Making biodiesel leaves behind crude glycerin, which the company can refine at minimal extra cost and sell for roughly three times the unrefined price. Polet said this upgrade could add up to $5 million to $10 million in annual profit starting in 2027.
💲 Other KPIs
Cash fell by $13.0 million from the second quarter and is down from $51.3 million at the end of 2025. Operations used $10.3 million in cash during the third quarter as the operating loss and higher biofuel working capital drained liquidity, while capital spending took another $3.3 million. The $35 million credit line remains untouched.
Money owed by customers rose from $20.1 million in the second quarter and $9.4 million at year-end, tracking the jump in biodiesel shipments. Over the first nine months, other noncurrent liabilities — where the company records upfront customer deposits for plant expansions — climbed by $12.7 million to $21.0 million, helping offset the working capital drain.
Diluted shares edged up 0.6% from a year ago and were unchanged from the second quarter. FutureFuel cut its quarterly dividend from $0.06 to $0.01 per share earlier this year to save cash for factory projects and opportunistic buybacks, but the nine-month cash flow statement shows no share repurchases so far in 2026.
🔮 Guidance
New. Polet expects about $7 million in fourth-quarter operating cash flow excluding one-offs, swinging back from a $4.9 million loss in the third quarter. That rebound includes $3.8 million of third-quarter spillover from $1.5 million of unsold fuel credits and $2.3 million of hedging recoveries, alongside normal chemical production with no major maintenance planned.
Unchanged. Management kept its target for positive full-year Adjusted EBITDA, excluding unrealized derivative moves and inventory valuation shifts. With the first nine months sitting at a $6.9 million loss, hitting the $7 million fourth-quarter plan leaves full-year Adjusted EBITDA barely above zero at roughly $71,000 by our math.
Updated timing. Total 2026 capital spending is set at $25.8 million, leaving $9.1 million for the fourth quarter by our math after $16.7 million spent in the first nine months. Customer-funded capex shifts from $10.2 million in 2026 to more than $26 million in 2027 as the $41 million two-year chemical expansion ramps up.
❓ Key Questions
Did the $22 million tax-credit cash arrive on schedule?
Last quarter management projected $3 million in third-quarter cash and $19 million in the fourth quarter from selling clean-fuel tax credits. The third-quarter release did not mention these proceeds while cash dropped by $13 million.
What is biodiesel profit per gallon at current soybean prices?
Even after adding back $3.8 million in delayed credits and hedge recoveries, the biofuel segment lost $6.0 million by our math at 83% utilization. Investors need to know what feedstock price allows the plant to break even.
How much capital spending goes to the glycerin upgrade?
Polet expects refining crude glycerin to add $5 million to $10 million in annual profit starting in 2027 at minimal cost. Management has not stated the exact equipment bill, timeline, or customer commitments for the refined output.
How much of the chemical segment relies on energy buyers?
The release again credited higher energy-market volumes for lifting chemical gross profit against last year. Without a revenue share for oil and gas customers, it is hard to tell how much of the chemical recovery is cyclical.